Supplementary_material.docx (231.12 kB)
Download file

Supplementary figure 1. Per-patient all-cause and treatment-related grade 3/4 AE costs over 42 months

Download (231.12 kB)
posted on 2022-01-12, 12:02 authored by Daniel M. Geynisman, Ella X. Du, Xiaoran Yang, Selvam R. Sendhil, Viviana Del Tejo, Keith A. Betts, Stephen Huo
  1. (a) Grade 3/4 AE costs, all treated population; (b) Grade 3/4 AE costs, all treated patients with intermediate/poor risk.


Bristol-Myers Squibb